secwatch.observer — SEC 8-K summary
======================================

Issuer:     EUDA Health Holdings Ltd (EUDA)
CIK:        0001847846
Form:       8-K
Filed at:   2022-06-01T23:59:59+00:00
Accession:  0001493152-22-015543
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

8i Acquisition 2 extends due diligence for EUDA Health combination to June 15, 2022
--------------------------------------------------------------------------------

- Parties amended the Share Purchase Agreement on May 30, 2022.
- Due diligence review period extended from May 31, 2022 to June 15, 2022.
- Amendment involves LAX, EUDA Health, Watermark Developments, and representative Kwong Yeow Liew.
- Business combination to be effected through purchase of all EUDA Health shares by LAX.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847846/000149315222015543/0001493152-22-015543-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847846/000149315222015543/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-015543

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer